Journal of Medical Economics, Volume 22, Issue 2 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 22, Issue 2 (2019)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Volume 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Oncology

Article
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma
Thomas E. Delea, Arati Sharma, Aaron Grossman, Caitlin Eichten, Keenan Fenton, Neil Josephson, Akshara Richhariya & Alison J. Moskowitz
Pages: 117-130
Published online: 10 Dec 2018
AbstractforCost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 2621 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective
David Hildick-Smith, Mark Turner, Louise Shaw, Mitesh Nakum, Bríain Ó Hartaigh, Richard M. Evans, John F. Rhodes, Lars Sondergaard & Scott E. Kasner
Pages: 131-139
Published online: 29 Nov 2018
AbstractforEvaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective | Full Text | References | PDF (1 MB) | EPUB
  • 1317 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Precision Medicine

Article
Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer
James Signorovitch, Zhou Zhou, Jason Ryan, Rachel Anhorn & Anita Chawla
Pages: 140-150
Published online: 21 Dec 2018
AbstractforBudget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 4017 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis
Timo Purmonen, Soili Törmälehto, Hanna Wahlman & Kari Puolakka
Pages: 151-157
Published online: 04 Dec 2018
AbstractforBudget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis | Full Text | References | PDF (870.3 KB) | EPUB
  • 1339 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Pharmacology

Article
Polymyxin B and colistin—the economic burden of nephrotoxicity against multidrug resistant bacteria
Felipe F. Tuon, Jaime L. Rocha & Juliano Gasparetto
Pages: 158-162
Published online: 13 Dec 2018
AbstractforPolymyxin B and colistin—the economic burden of nephrotoxicity against multidrug resistant bacteria | Full Text | References | PDF (608.2 KB) | EPUB
  • 1266 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt
Gihan Hamdy Elsisi, Yousery Nada, Noha Rashad & João Carapinha
Pages: 163-168
Published online: 13 Dec 2018
AbstractforCost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt | Full Text | References | PDF (907.6 KB) | EPUB
  • 1838 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry

Article
A discrete-choice experiment to assess treatment modality preferences of patients with anxiety disorder
Joran Lokkerbol, Julia M. van Voorthuijsen, Amber Geomini, Bea Tiemens, Annemieke van Straten, Filip Smit, Anneriek Risseeuw, Anton van Balkom & Mickaël Hiligsmann
Pages: 169-177
Published online: 22 Dec 2018
AbstractforA discrete-choice experiment to assess treatment modality preferences of patients with anxiety disorder | Full Text | References | PDF (1 MB) | EPUB
  • 1475 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
A discrete-choice experiment to assess treatment modality preferences of patients with depression
Joran Lokkerbol, Amber Geomini, Jule van Voorthuijsen, Annemieke van Straten, Bea Tiemens, Filip Smit, Anneriek Risseeuw & Mickaël Hiligsmann
Pages: 178-186
Published online: 22 Dec 2018
AbstractforA discrete-choice experiment to assess treatment modality preferences of patients with depression | Full Text | References | PDF (1.4 MB) | EPUB
  • 2364 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
Lei Wu & Lixian Zhong
Pages: 187-195
Published online: 04 Jan 2019
AbstractforBudget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US | Full Text | References | PDF (1.1 MB) | EPUB
  • 2219 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
The economic burden of psoriasis with high comorbidity among privately insured patients in the United States
Dominic Pilon, Amanda Teeple, Masha Zhdanava, Martin Ladouceur, Hoi Ching Cheung, Erik Muser & Patrick Lefebvre
Pages: 196-203
Published online: 03 Jan 2019
AbstractforThe economic burden of psoriasis with high comorbidity among privately insured patients in the United States | Full Text | References | PDF (890.8 KB) | EPUB | Supplemental
  • 2256 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles